Alnylam Pharmaceuticals, Inc. (ALNY) vs Cardinal Health, Inc. (CAH)
CAH leads on 7 of 13 compared metrics.
A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and Cardinal Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 20, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
ALNY
Alnylam Pharmaceuticals, Inc.
$272.67HealthcareDelayed quote: Jul 20, 2026, 4:00 PM EDT
CAH
Cardinal Health, Inc.
$225.75HealthcareDelayed quote: Jul 20, 2026, 4:00 PM EDT
Total return — ALNY vs CAH
growth of $100 · dividends reinvested · last 22yALNY +4444.9%CAH +434.2%ALNY compounded faster
Log scale — wide-divergence pair
ALNY CAH
ALNY vs CAH: by the numbers
- •CAH is the larger company ($52.87B vs $36.40B market cap).
- •CAH trades at the lower earnings multiple (34.52 vs 63.53 P/E).
- •ALNY converts more revenue to profit (13.46% vs 0.62% net margin).
- •ALNY grew revenue faster over the past five years (49.67% vs 9.86% CAGR).
- •CAH pays a dividend (0.91% yield) while ALNY does not currently pay one.
Which is better, ALNY or CAH?
Metric tally: ALNY 6 · CAH 7It depends on what you're optimizing for:
ValueCAH(lower P/E)
GrowthALNY(faster 5Y revenue CAGR)
QualityALNY(higher ROIC)
Metrics side by side
Valuation
| Metric | ALNY | CAH |
|---|---|---|
| P/E ratio | 63.53 | 34.52● |
| Forward P/E | 35.91 | 20.95● |
| P/S ratio | 8.62 | 0.21● |
| P/B ratio | 34.38 | — |
| PEG ratio | — | 0.30 |
| EV / EBITDA | 45.27 | 18.39● |
| FCF yield | 1.73% | 8.24%● |
Profitability
| Metric | ALNY | CAH |
|---|---|---|
| Gross margin | 80.89%● | 3.68% |
| Operating margin | 17.54%● | 0.92% |
| Net margin | 13.46%● | 0.62% |
| ROE | 53.68%● | -56.13% |
| ROIC | 13.74%● | 11.37% |
Dividends
| Metric | ALNY | CAH |
|---|---|---|
| Dividend yield | — | 0.91% |
| Payout ratio | — | 31.60% |
Growth (annualized)
| Metric | ALNY | CAH |
|---|---|---|
| Revenue CAGR (5Y) | 49.67%● | 9.86% |
| EPS CAGR (5Y) | — | 6.11% |
| FCF CAGR (5Y) | 14.35% | 22.47%● |
| Total return CAGR (5Y) | 8.32% | 34.28%● |
Frequently asked
- Which is better, ALNY or CAH?
- It depends on your goal. value: CAH (lower P/E); growth: ALNY (faster 5Y revenue CAGR); quality: ALNY (higher ROIC). Across all compared metrics, CAH leads 7 to 6.
- Is ALNY or CAH cheaper?
- On trailing earnings, CAH is cheaper: ALNY trades at a 63.53 P/E and CAH at 34.52.
- Which has grown faster, ALNY or CAH?
- Over the past five years, ALNY grew revenue faster — ALNY at a 49.67% CAGR versus CAH at 9.86%.
- Does ALNY or CAH pay a bigger dividend?
- CAH pays a dividend (0.91% yield) while ALNY does not currently pay one.
- Is ALNY or CAH more profitable?
- ALNY runs the higher net margin — ALNY at 13.46% versus CAH at 0.62%.
- Which has been the better investment, ALNY or CAH?
- Over the past 10-year, ALNY delivered the higher annualized total return — ALNY at 15.31% versus CAH at 13.61%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Alnylam Pharmaceuticals P/E ratioCardinal Health P/E ratioAlnylam Pharmaceuticals dividend yieldCardinal Health dividend yieldAlnylam Pharmaceuticals ROECardinal Health ROEAlnylam Pharmaceuticals operating marginCardinal Health operating marginAlnylam Pharmaceuticals revenue growthCardinal Health revenue growthAlnylam Pharmaceuticals free cash flowCardinal Health free cash flow
Alnylam Pharmaceuticals & Cardinal Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 20, 2026.